Literature DB >> 7442125

Chronic demyelination inhibits remyelination in the central nervous system. An analysis of contributing factors.

S K Ludwin.   

Abstract

The remyelinative capacity of the central nervous system was investigated in the superior cerebellar peduncles of mice chronically demyelinated for 6 to 7 months by the administration of Cuprizone. It was found that, although the axons retained their capacity for remyelination, this capacity was greatly reduced compared to acutely demyelinated animals. The possible causes for this reduction were examined, and it was concluded that the limiting factor was the decreased availability of oligodendrocytes for remyelination, rather than inherent factors in the axons, or changes in the surrounding glial environment. The implications for both experimental and clinical disease are discussed.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7442125

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  33 in total

1.  Multiple sclerosis: An old drug plays a new trick.

Authors:  Hartmut Wekerle; Edgar Meinl
Journal:  Nature       Date:  2013-10-09       Impact factor: 49.962

2.  Stimulation of adult oligodendrogenesis by myelin-specific T cells.

Authors:  Helle Hvilsted Nielsen; Henrik Toft-Hansen; Kate Lykke Lambertsen; Trevor Owens; Bente Finsen
Journal:  Am J Pathol       Date:  2011-08-26       Impact factor: 4.307

3.  Spontaneous remyelination following extensive demyelination is associated with improved neurological function in a viral model of multiple sclerosis.

Authors:  P D Murray; D B McGavern; S Sathornsumetee; M Rodriguez
Journal:  Brain       Date:  2001-07       Impact factor: 13.501

4.  Node-like axonal specializations along demyelinated central nerve fibres: ultrastructural observations.

Authors:  W F Blakemore; K J Smith
Journal:  Acta Neuropathol       Date:  1983       Impact factor: 17.088

5.  The demonstration of recurrent demyelination and remyelination of axons in the central nervous system.

Authors:  E S Johnson; S K Ludwin
Journal:  Acta Neuropathol       Date:  1981       Impact factor: 17.088

Review 6.  Stem cell therapy for central nervous system demyelinating disease.

Authors:  Louis N Manganas; Mirjana Maletic-Savatic
Journal:  Curr Neurol Neurosci Rep       Date:  2005-05       Impact factor: 5.081

7.  Activation of inflammatory response by a combination of growth factors in cuprizone-induced demyelinated brain leads to myelin repair.

Authors:  Juan Carlos Biancotti; Shalini Kumar; Jean de Vellis
Journal:  Neurochem Res       Date:  2008-07-26       Impact factor: 3.996

8.  Oligodendrocytes and progenitors become progressively depleted within chronically demyelinated lesions.

Authors:  Jeffrey L Mason; Arrel Toews; Janell D Hostettler; Pierre Morell; Kinuko Suzuki; James E Goldman; Glenn K Matsushima
Journal:  Am J Pathol       Date:  2004-05       Impact factor: 4.307

9.  Benign form of multiple sclerosis: MRI evidence for less frequent and less inflammatory disease activity.

Authors:  D Kidd; A J Thompson; B E Kendall; D H Miller; W I McDonald
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-09       Impact factor: 10.154

Review 10.  Debris clearance by microglia: an essential link between degeneration and regeneration.

Authors:  H Neumann; M R Kotter; R J M Franklin
Journal:  Brain       Date:  2008-06-20       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.